Sep 2024
Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification
<p>In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ... Show More
31m 56s
Sep 2024
Episode 115: AML Series, Pt. 1 - CHIP, CCUS, ICUS, oh my!
<p>This week, we kick off a new series focusing on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this first episode, we discuss the alphabet soup of premalignant hematologic conditions including CHIP, CCUS, and ICUS, before moving onto MDS and AML in future ... Show More
35m 14s
Dec 2024
Episode 124: AML Series, Pt 10 - Allogeneic transplant for AML
<p data-rte-preserve-empty="true" style="white-space:pre-wrap;">In today’s episode, we welcome back Dr. Amar Kelkar for part 2 of our two-part discussion on allogeneic transplant. In this episode, we build on our prior discussion regarding transplant, this time focusing on transp ... Show More
26m 12s
Apply for GFM Coaching here
There is NOTHING more valuable to a podcast than leaving a written review and a 5-Star Rating. If you enjoyed the episode, please take 1 minute to leave a rating and review for iTunes HERE: https://podcasts.apple.com/au/podcast
You can a review on Spotify HERE:https://open.spotify.com/show/4nDhr80
Click here to download your FRE ... Show More
<p>In Part 3 of our Heme Path series, we break down the basics of immunohistochemistry (IHC)</p><p>Episode contents: </p><p>- What is immunohistochemistry? </p><p>- What are the pros and cons? </p><p>- How do we use this clinically? </p><p>****Have some time and want to make some ... Show More
<p class="" style="white-space:pre-wrap;">It’s time for another Heme Consult series, this time focusing on another common question we see in the hospital and in clinic: “is this anticoagulation failure?”</p><p class="" style="white-space:pre-wrap;">In this two-part series, we bre ... Show More